Small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/20/suppl_4/iv71/345606/mdp133.pdf
Reference14 articles.
1. The International Association for the Study of Lung Cancer Staging Project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the Tumor, Node, Metastasis Classification for Lung Cancer;Shepherd;J Thorac Oncol,2007
2. Cisplatin and etoposide regimen is superior to cyclophosphanide, epirubicin, and vincristine regimen in small cell lung cancer: results form a randomized phase III trial with 5 years’ follow-up;Sundstrom;J Clin Oncol,2002
3. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent;Pujol;Br J Cancer,2000
4. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. European Lung Cancer Working Party (ELCWP);Mascaux;Lung Cancer,2000
5. A meta-analysis of thoracic radiotherapy for small cell lung cancer;Pignon;N Engl J Med,1992
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prophylactic cranial irradiation for limited‐stage small‐cell lung cancer in the magnetic resonance imaging era;Cancer Medicine;2022-07-27
2. Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer;JAMA Oncology;2019-03-14
3. Clinical features and prognostic factors of small cell lung cancer: A retrospective study in 148 patients;Journal of Huazhong University of Science and Technology [Medical Sciences];2016-12
4. Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer;The Analyst;2016
5. Hyponatrémie sévère sous chimiothérapie du carcinome à petites cellules;Revue des Maladies Respiratoires;2015-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3